PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

Allen, T. M., Hansen, C., Martin, F., Redemann, C. T., & Yau‐Young, A. O. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,392

Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens

Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 987

T Cell-Independent Antigens Type 2

Mond, J. J., Lees, A., & Snapper, C. M. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.003255 · Cited by 833

Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes

Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 606

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 558

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

Lasiç, D. D., Martin, F. J., Gabizón, A., Huang, S. K., & Papahadjopoulos, D. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90162-2 · Cited by 545

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles

Senior, J. H., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521

Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity

Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Jr., Trubetskoy, V. S., Herron, J. N., & Gentry, C. A. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90003-5 · Cited by 466

Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles

Khoshnejad, M., Shuvaev, V. V., Pulsipher, K. W., Dai, C., Hood, E. D., Arguiri, E., Christofidou‐Solomidou, M., Dmochowski, I. J., Greineder, C. F., & Muzykantov, V. R. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00641 · Cited by 34

Mechanical Properties and Concentrations of Poly(ethylene glycol) in Hydrogels and Brushes Direct the Surface Transport of Staphylococcus aureus

Kolewe, K. W., Kalasin, S., Shave, M. K., Schiffman, J. D., & Santore, M. M. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18302 · Cited by 33

Unravelling Heterogeneities in Complement and Antibody Opsonization of Individual Liposomes as a Function of Surface Architecture

Münter, R., Stavnsbjerg, C., Christensen, E., Thomsen, M. E., Stensballe, A., Hansen, A. E., Parhamifar, L., Kristensen, K., Simonsen, J. B., Larsen, J. B., et al. (2022) · Small · doi:10.1002/smll.202106529 · Cited by 35

Enhanced treatment for cerebral ischemia-reperfusion injury of puerarin loading liposomes through neutrophils-mediated targeted delivery

Liu, W. D., Lu, H., Rao, X.-Y., Li, X., Lu, H., Li, F., He, Y., Yu, R., Zhong, R., Zhang, Y., et al. (2021) · Nano Research · doi:10.1007/s12274-021-3395-y · Cited by 32

Determining the Relationship between Nanoparticle Characteristics and Immunotoxicity: Key Challenges and Approaches

David, C. A. W., Owen, A., & Liptrott, N. J. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0017 · Cited by 33

Development of Liposomal Anticancer Drugs

Hyodo, K., Yamamoto, E., Suzuki, T., Kikuchi, H., Asano, M., & Ishihara, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-01106 · Cited by 30

Shell-crosslinked knedel-like nanoparticles induce lower immunotoxicity than their non-crosslinked analogs

Elsabahy, M., Samarajeewa, S., Raymond, J. E., Clark, C., & Wooley, K. L. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20668h · Cited by 30

A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice

Abu‐Dief, A. M., Alsehli, M., & Awaad, A. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-022-02086-0 · Cited by 30

Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase

Zhang, C., Fan, K. C., Ma, X., & Wei, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039659 · Cited by 30

Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review

Maestrelli, F., Bragagni, M., & Mura, P. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.09.011 · Cited by 29

The effects of superparamagnetic iron oxide nanoparticles-labeled mesenchymal stem cells in the presence of a magnetic field on attenuation of injury after heart failure

Naseroleslami, M., Aboutaleb, N., & Parivar, K. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0567-8 · Cited by 29

Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities

Wang, H., Lin, S., Wu, X., Jiang, K., Lu, H., & Zhan, C. (2023) · Advanced Science · doi:10.1002/advs.202301777 · Cited by 28

Ex-Vivo/in-Vitro Anti-polyethylene Glycol (PEG) Immunoglobulin M Production from Murine Splenic B Cells Stimulated by PEGylated Liposome

Lila, A. S. A., Ichihara, M., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00562 · Cited by 28

Suppression of the Reticuloendothelial System Using λ-carrageenan to Prolong the Circulation of Gold Nanoparticles

Magaña, I. B., Yendluri, R., Adhikari, P., Goodrich, G. P., Schwartz, J. A., Sherer, E. A., & O’Neal, D. P. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.33 · Cited by 28

Accelerated Blood Clearance (ABC) Phenomenon Induced by Administration of PEGylated Liposome

Ishida, T., & Kiwada, H. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.233 · Cited by 28

Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes

Shimizu, T., Awata, M., Lila, A. S. A., Yoshioka, C., Kawaguchi, Y., Ando, H., Ishima, Y., & Ishida, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.033 · Cited by 27

A noticeable phenomenon: Thiol terminal PEG enhances the immunogenicity of PEGylated emulsions injected intravenously or subcutaneously into rats

Wang, C., Cheng, X., Sui, Y., Luo, X., Jiang, G., Wang, Y., Huang, Z., She, Z., & Deng, Y. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.002 · Cited by 27

B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice

Hashimoto, Y., Lila, A. S. A., Shimizu, T., Ishida, T., & Kiwada, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.003 · Cited by 27

The Application of Nanotechnology to Drug Delivery in Medicine

McDonald, T. O., Siccardi, M., Moss, D. M., Liptrott, N. J., Giardiello, M., Rannard, S. P., & Owen, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62747-6.00007-5 · Cited by 26

IgA and IgM protein primarily drive plasma corona‐induced adhesion reduction of PLGA nanoparticles in human blood flow

Sobczynski, D. J., & Eniola‐Adefeso, O. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10064 · Cited by 29

Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon

Su, Y., Liu, M., Xiong, Y., Ding, J., Liu, X., Song, Y., & Deng, Y. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0588-3 · Cited by 26

Evasion from accelerated blood clearance of nanocarrier named as “Lactosome” induced by excessive administration of Lactosome

Hara, E., Makino, A., Kurihara, K., Sugai, M., Shimizu, A., Hara, I., Ozeki, E., & Kimura, S. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.024 · Cited by 26

Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model

Agashe, H. B., Lagisetty, P., Sahoo, K. K., Bourne, D. W. A., Grady, B. P., & Awasthi, V. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-0154-5 · Cited by 27

Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model

Shimizu, T., Lila, A. S. A., Nishio, M., Doi, Y., Ando, H., Ukawa, M., Ishima, Y., & Ishida, T. (2017) · Cancer Science · doi:10.1111/cas.13305 · Cited by 26

The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia

Guo, J., Luan, X., Cong, Z., Sun, Y., Wang, L., McKenna, S. L., Cahill, M. R., & O’Driscoll, C. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.024 · Cited by 26

Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions

Liu, M., Zhao, D., Yan, N. J., Li, J., Zhang, H., Liu, M., Tang, X., Liu, X., Deng, Y., Song, Y., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121365 · Cited by 25

A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes

Talkington, A., McSweeney, M. D., Wessler, T., Rath, M. K., Li, Z., Zhang, T., Yuan, H., Frank, J. E., Forest, M. G., Cao, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.022 · Cited by 27

Intracellular calcium is a target of modulation of apoptosis in MCF-7 cells in the presence of IgA adsorbed to polyethylene glycol

França, E. L., Honório‐França, A. C., Nunes, G., Fagundes, D. L. G., de Marchi, P. G. F., Fernandes, R. T. D. S., França, J., Botelho, A., Varotti, F. D. P., & Moraes, L. C. A. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99839 · Cited by 24

Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats

Fang, J., Vanlandingham, M. M., Beland, F. A., Felton, R. P., Maisha, M. P., Olson, G. R., Patton, R. E., Rosenberg, A. S., & da Costa, G. G. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.01.011 · Cited by 23

Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine

Shen, L., Li, Z., Ma, A. L., Cruz-Teran, C. A., Talkington, A., Shipley, S. T., & Lai, S. K. (2024) · ACS Nano · doi:10.1021/acsnano.3c11165 · Cited by 24

Cancer Therapy with Nanotechnology-Based Drug Delivery Systems: Applications and Challenges of Liposome Technologies for Advanced Cancer Therapy

Suzuki, R., Omata, D., Oda, Y., Unga, J., Negishi, Y., & Maruyama, K. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_23 · Cited by 24

Transport in PEG‐Based Hydrogels: Role of Water Content at Synthesis and Crosslinker Molecular Weight

Stocke, N. A., Zhang, X., Hilt, J. Z., & DeRouchey, J. E. (2016) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201600340 · Cited by 24

Enhanced Opsonization-Independent Phagocytosis and High Response Ability to Opsonized Antigen–Antibody Complexes: A New Role of Kupffer Cells in the Accelerated Blood Clearance Phenomenon upon Repeated Injection of PEGylated Emulsions

Cheng, X., Wang, C., Su, Y., Luo, X., Liu, X., Song, Y., & Deng, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00019 · Cited by 23

Blood retention and antigenicity of polycarboxybetaine-modified liposomes

Ryujin, T.-A., Shimizu, T., Miyahara, R., Asai, D., Shimazui, R., Yoshikawa, T., Kishimura, A., Mori, T., Ishida, T., & Katayama, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119521 · Cited by 23

Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens

Li, B., Chu, F., Lu, Q., Wang, Y., & Lane, L. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.047 · Cited by 23

Liposomal delivery of gene therapy for ovarian cancer: a systematic review

Son, J. S., Chow, R., Kim, H., Lieu, T., Xiao, M., Kim, S. W., Matuszewska, K., Pereira, M., Nguyen, D. L., & Petrik, J. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01125-2 · Cited by 23

Nanolipid Materials for Drug Delivery Systems

Negi, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00006-4 · Cited by 23

Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow

Sobczynski, D. J., & Eniola‐Adefeso, O. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.023 · Cited by 22

Immunological responses to PEGylated proteins

Elsadek, N. E., Lila, A. S. A., & Ishida, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64081-9.00005-x · Cited by 22

Role of stealth lipids in nanomedicine-based drug carriers

Rastogi, M., Saha, R. N., Alexander, A., Singhvi, G., Puri, A., & Dubey, S. K. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105036 · Cited by 22

Effect of Antigen Structure in Subunit Vaccine Nanoparticles on Humoral Immune Responses

Park, J., & Champion, J. A. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01516 · Cited by 21

PEGylation and anti-PEG antibodies

Lila, A. S. A., Shimizu, T., & Ishida, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00003-9 · Cited by 23

Development of a Generic Anti-PEG Antibody Assay Using BioScale’s Acoustic Membrane MicroParticle Technology

Dong, H., Mora, J. R., Brockus, C. L., Chilewski, S. D., Dodge, R. W., Merrifield, C., Dickerson, W. M., & Desilva, B. S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9799-4 · Cited by 21

Perfluorocarbon nanodroplet size, acoustic vaporization, and inertial cavitation affected by lipid shell composition in vitro

Welch, P. J., Li, D. S., Forest, C. R., Pozzo, L. D., & Shi, C. (2022) · The Journal of the Acoustical Society of America · doi:10.1121/10.0014934 · Cited by 19

Anti-PEG IgM Production via a PEGylated Nano-Carrier System for Nucleic Acid Delivery

Ichihara, M., Moriyoshi, N., Lila, A. S. A., Ishida, T., & Kiwada, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-140-0_4 · Cited by 19

Biomimetic approaches against accelerated blood clearance (ABC) phenomenon of nanoparticulate drug delivery systems

Jan, N., Shah, H., & Shi, G. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125753 · Cited by 18

Nanoliposomes as nonviral vectors in cancer gene therapy

Yildiz, Ş., Entezari, M., Paskeh, M. D. A., Mirzaei, S., Kalbasi, A., Zabolian, A., Hashemi, F., Hushmandi, K., Hashemi, M., Raei, M., et al. (2024) · MedComm · doi:10.1002/mco2.583 · Cited by 18

Construction of biomimetic long-circulation delivery platform encapsulated by zwitterionic polymers for enhanced penetration of blood–brain barrier

Wang, N., Jin, X., & Zhu, X. (2017) · RSC Advances · doi:10.1039/c7ra01532a · Cited by 18

Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens

Ando, H., Lila, A. S. A., Kawanishi, M., Shimizu, T., Okuhira, K., Ishima, Y., & Ishida, T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.002 · Cited by 18

PEG–protein conjugates

Turecek, P. L., & Siekmann, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64081-9.00004-8 · Cited by 18

Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration

Su, Y., Liu, M., Liang, K., Liu, X., Song, Y., & Deng, Y. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1120-2 · Cited by 18

Liposomes and PEGylated liposomes as drug delivery system

Mohamed, M., Alaaeldin, E., Hussein, A. K., & Sarhan, H. A. (2020) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2020.22937.1068 · Cited by 17

High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies

Talkington, A., McSweeney, M. D., Zhang, T., Li, Z., Nyborg, A. C., LaMoreaux, B. D., Livingston, E. W., Frank, J. E., Yuan, H., & Lai, S. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.051 · Cited by 18

The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin

Su, Y., Wang, L., Liang, K., Liu, M., Liu, X., Song, Y., & Deng, Y. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.07.003 · Cited by 17

Extracellular and Intracellular Barriers to Non-Viral Gene Transfer

Lynn, F., & David, A. (2013) · InTech eBooks · doi:10.5772/54699 · Cited by 18

Temperature- and pH-sensitive Polymeric Micelles for Drug Encapsulation, Release and Targeting

Sosnik, A. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849736800-00115 · Cited by 17

Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines

Shiraishi, K. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2538423 · Cited by 19

Development and characterization of an innovative heparin coating to stabilize and protect liposomes against adverse immune reactions

Duehrkop, C., Leneweit, G., Heyder, C., Fromell, K., Edwards, K., Ekdahl, K. N., & Nilsson, B. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.02.014 · Cited by 16

A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes

Sayed, M. M. E., Shimizu, T., Lila, A. S. A., Elsadek, N. E., Emam, S. E., Alaaeldin, E., Kamal, A., Sarhan, H. A., Ando, H., Ishima, Y., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121539 · Cited by 16

Advancements in nanomedicines for the detection and treatment of diabetic kidney disease

Tillman, L., Tabish, T. A., Kamaly, N., Moss, P., El-briri, A., Thiemermann, C., Pranjol, M. Z. I., & Yaqoob, M. M. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100047 · Cited by 16

Comprehensive analysis of PEGylated liposome‐associated proteins relating to the accelerated blood clearance phenomenon by combination with shotgun analysis and conventional methods

Kawanishi, M., Hashimoto, Y., Shimizu, T., Sagawa, I., Ishida, T., & Kiwada, H. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1291 · Cited by 16

Tolerance-like innate immunity and spleen injury: a novel discovery via the weekly administrations and consecutive injections of PEGylated emulsions

Deng, Y., Wang, L., Wang, C., Jiao, J., Su, Y., Cheng, X., Huang, Z., & Liu, X. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s66318 · Cited by 16

Cell-specific delivery of biologicals: problems, pitfalls and possibilities of antifibrotic compounds in the liver

Poelstra, K., Beljaars, L., & Melgert, B. N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.013 · Cited by 16

A polymer-free, biomimicry drug self-delivery system fabricated via a synergistic combination of bottom-up and top-down approaches

Xu, X., Yang, G., Xue, X., Lu, H., Wu, H., Huang, Y., Jing, D., Xiao, W., Tian, J., Yao, W., et al. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01464g · Cited by 16

Elucidation of Accelerated Blood Clearance Phenomenon Caused by Repeat Injection of PEGylated Nanocarriers

Koide, H., Asai, T., Hatanaka, K., Shimizu, K., Yokoyama, M., Ishida, T., Kiwada, H., & Oku, N. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.1445 · Cited by 16

Application of nanoparticles in the treatment of acute lung injury: Current situation and future directions

Zhang, Y., Sun, W., Wang, M., Qian, Y., Zheng, Q., Wang, W., Yang, H., Wang, Y., Zhou, M., Wang, X., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102199 · Cited by 15

The Co-Delivery of Oxaliplatin Abrogates the Immunogenic Response to PEGylated siRNA-Lipoplex

Alaaeldin, E., Lila, A. S. A., Moriyoshi, N., Sarhan, H. A., Ishida, T., Khaled, K. A., & Kiwada, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1078-4 · Cited by 15

Case Study: Complement Activation Related Hypersensitivity Reactions to PEGylated Liposomal Doxorubicin — Experimental and Clinical Evidence, Mechanisms and Approaches to Inhibition

Szebeni, J., Muggia, F. M., & Barenholz, Y. (2016) · Frontiers in nanobiomedical research · doi:10.1142/9789813140455_0010 · Cited by 15

The surface-first paradigm: Engineering nanocarriers for infection-responsive drug delivery

Shah, R. M., Kaur, I. P., & Jadhav, S. R. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103761 · Cited by 16

Cell and organ drug targeting

Himri, I., & Guaâdaoui, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813665-2.00001-6 · Cited by 14

PEGylated Nanoparticles as a Versatile Drug Delivery System

Mohapatra, P., Singh, D., & Sahoo, S. K. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch10 · Cited by 14

“Y-type” PEG modified liposomes could eliminate the accelerated blood clearance (ABC) phenomenon and improved tumor therapy

Liu, M., Liu, S., Xiu, J., Zhang, J., Deng, Y., & Zhao, X. (2023) · Applied Materials Today · doi:10.1016/j.apmt.2023.101853 · Cited by 13

Polyesters and Polyester Nano- and Microcarriers for Drug Delivery

Słomkowski, S., Basińska, T., Gadzinowski, M., & Mickiewicz, D. (2024) · Polymers · doi:10.3390/polym16172503 · Cited by 13

Water-soluble polymers bearing phosphorylcholine group and other zwitterionic groups for carrying DNA derivatives

Lin, X., & Ishihara, K. (2014) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2014.934319 · Cited by 13

Control of in vivo disposition and immunogenicity of polymeric micelles by adjusting poly(sarcosine) chain lengths on surface

Kurihara, K., Ueda, M., Hara, I., Ozeki, E., Togashi, K., & Kimura, S. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-3936-1 · Cited by 13

Novel Development of Nanoparticles—A Promising Direction for Precise Tumor Management

Zhang, D., Tang, Q., Chen, J., Wei, Y., & Chen, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010024 · Cited by 14

PEG-detachable lipid–polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells

Du, J., Song, Y., Ye, W., Cheng, Y., Cui, H., Liu, D., Liu, M., Zhang, B., & Zhou, S. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000092 · Cited by 13

Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma

Deodhar, S., Dash, A. K., North, E. J., & Hulce, M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01745-6 · Cited by 13

Unravelling Ligand Conjugation Performance in Extracellular Vesicles: A Quantitative Assessment of Lipid, Protein, and Membrane Modifications

Pan, X., Zhang, S., Xia, L., Sun, M., Su, X., Ke, Y., Zhang, T., Su, L., Lian, J., Wu, S., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70174 · Cited by 13

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities

Mihindukulasooriya, S. P., Wang, Z., Li, S., Saini, A., Wilson, K., Plebanski, M., Kent, S. J., & Ju, Y. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115925 · Cited by 17

Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines

Shimizu, T., Kawaguchi, Y., Ando, H., Ishima, Y., & Ishida, T. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00047 · Cited by 12

Surface energy of phospholipid bilayers and the correlation to their hydration

Klapper, Y., Vrânceanu, M., Ishitsuka, Y., Evans, D., Scheider, D., Nienhaus, G. U., & Leneweit, G. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.09.027 · Cited by 12

Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism

Elsadek, N. E., Emam, S. E., Lila, A. S. A., Shimizu, T., Ando, H., Ishima, Y., & Ishida, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00345 · Cited by 12

Repeated Injection of High Doses of Hemoglobin-Encapsulated Liposomes (Hemoglobin Vesicles) Induces Accelerated Blood Clearance in a Hemorrhagic Shock Rat Model

Taguchi, K., Iwao, Y., Watanabe, H., Kadowaki, D., Sakai, H., Kobayashi, K., Horinouchi, H., Maruyama, T., & Otagiri, M. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036913 · Cited by 11

Nanotoxicology: Towards Safety by Design

Andón, F. T., & Fadeel, B. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_14 · Cited by 10

Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated‐Granulocyte Colony‐Stimulating Factor

Okada, N., Shimizu, T., Ando, H., Nakamura, S., Goda, M., Abe, M., Kitahara, T., Ishida, T., & Ishizawa, K. (2023) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1225 · Cited by 11

Application of Mass Spectrometry to Characterize Localization and Efficacy of Nanoceria In Vivo

Heckman, K. L., Erlichman, J. S., Reed, K., & Skeels, M. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-06068-2_28 · Cited by 10

Mixed PEGylated surfactant modifying system decrease the accelerated blood clearance phenomenon of nanoemulsions in rats

Su, Y., Tang, W., Song, Y., Wang, C., Tian, Q., Wang, X., Quan, J., Li, B., Wang, S., & Deng, Y. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.07.003 · Cited by 10

Historical Introduction to the Field of Controlled Drug Delivery

(2016) · CRC Press eBooks · doi:10.1201/9781315382579-2 · Cited by 10

Nanostability

Cauerhff, A., Martinez, Y. N., Islan, G. A., & Castro, G. R. (2013) · Nanomedicine and nanotoxicology · doi:10.1007/978-1-4614-8993-1_3 · Cited by 10

Polyphosphocholination of liposomic vehicles extends blood circulation, enhances cellular uptake, and lowers immunogenicity relative to PEGylation

Kluzek, M., Hamad, M., Lin, W., Mitsou, E., Porat, Z., Kuznetsov, Y., Oppenheimer‐Shaanan, Y., & Klein, J. E. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114306 · Cited by 10

Immune‐responsive biodegradable scaffolds for enhancing neutrophil regeneration

Kerr, M. D., McBride, D. A., Johnson, W. T., Chumber, A. K., Najibi, A. J., Seo, B. R., Stafford, A. G., Scadden, D. T., Mooney, D. J., & Shah, N. J. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10309 · Cited by 8

Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats

Subasic, C. N., Butcher, N. J., Minchin, R. F., & Kaminskas, L. M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00104 · Cited by 9

Fibrillous Carbon Nanotube: An Unexpected Journey

McDevitt, M. R., & Scheinberg, D. A. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014011442 · Cited by 9

Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice.

Qelliny, M., Shimizu, T., Elsadek, N. E., Emam, S. E., Takata, H., Fathalla, Z. M., Hussein, A., Khaled, K., Ando, H., Ishima, Y., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00255 · Cited by 8

Protein-Free Hapten-Carbon Nanotube Constructs Induce the Secondary Immune Response

Ceballos-Alcantarilla, E., Abad‐Somovilla, A., Agulló, C., Abad‐Fuentes, A., & Mercader, J. V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00653 · Cited by 9

Poly(2-oxazoline) and poly(2-oxazine)-based nanomedicines: Advancements, opportunities and challenges

Humphries, J., Warne, N. M., Feeney, O. M., Thurecht, K. J., & Kempe, K. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114838 · Cited by 9

Escherichia coli Swimming back Toward Stiffer Polyetheylene Glycol Coatings, Increasing Contact in Flow

Shave, M. K., Xu, Z., Raman, V., Kalasin, S., Tuominen, M. T., Forbes, N. S., & Santore, M. M. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00245 · Cited by 8

siRNA: Sojourn from discovery to delivery challenges and clinics

Misra, A. R., Trehan, S., & Sharma, G. (2010) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.59507 · Cited by 13

Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules

Alaaeldin, E., Lila, A. S. A., Ando, H., Fukushima, M., Huang, C., Wada, H., Sarhan, H. A., Khaled, K. A., & Ishida, T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.040 · Cited by 8

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats

Ichihara, M., Shimizu, T., Imoto, A., Hashiguchi, Y., Uehara, Y., Ishida, T., & Kiwada, H. (2010) · Pharmaceutics · doi:10.3390/pharmaceutics3010001 · Cited by 157

Cellular mechanism for immunogenicity of PEGylated “stealth” liposomes (IRC3P.466)

Watanabe, A., Cain, D. W., Hanson, M. C., Kim, M., Reinherz, E. L., Irvine, D. J., & Kelsoe, G. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.192.supp.59.9 · Cited by 1

Ex-Vivo/in-Vitro Anti-polyethylene Glycol (PEG) Immunoglobulin M Production from Murine Splenic B Cells Stimulated by PEGylated Liposome

Lila, A. S. A., Ichihara, M., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00562 · Cited by 28

Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens

Ando, H., Lila, A. S. A., Kawanishi, M., Shimizu, T., Okuhira, K., Ishima, Y., & Ishida, T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.002 · Cited by 18

Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response

Shimizu, T., Ichihara, M., Yoshioka, Y., Ishida, T., Nakagawa, S., & Kiwada, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00276 · Cited by 96